PharmaVentures
PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances.
Listen on:
Episodes
Thursday Feb 23, 2023
Thursday Feb 23, 2023
Listen as Jansen Jacob and Steve Garland discuss how the future role of CDMOs in biopharmaceutical manufacturing will be affected by the challenges of cost, new modalities and new innovation; cell and gene therapy (CGT), and personalised medicine. Hosted by Adrian Dawkes.
Wednesday Nov 09, 2022
Wednesday Nov 09, 2022
Listen as PharmaVentures’ Pricing and Market Access expert, Ralph Hughes, recommends elements of a robust plan to help you achieve the best pricing and market access for your drug, and to give you the increased confidence to strengthen your position during deal making negotiations. Hosted by Adrian Dawkes.
Let's Talk
In this series of monthly podcasts, PharmaVentures will provide you with additional insights into life sciences deal making.
PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support businesses in all aspects of deal making and strategic planning.
To speak with our experts further about the subject of this podcast, life sciences M&A, licensing, fundraising, strategy, valuations, or pricing and market access, please email enquiries@pharmaventures.com